NeuRemedy, "The Neuropathy Vitamin"

A Nutritional Approach to Managing the Debilitating Symptoms of Peripheral Neuropathy
Peripheral neuropathy is a common debilitating condition of the peripheral nerves which often causes pain, numbness, and tingling of the feet and legs. It is estimated that approximately 20 million people are currently suffering from peripheral neuropathy in the United States. It is believed that more than one half of these cases go undiagnosed.
Until recently, the mainstay of treatment for peripheral neuropathy was the use of drugs that sedate and suppress nervous system function. Today, there is a new paradigm. Instead of sedating their patients, many doctors have discovered that they can successfully manage their patient's symptoms nutritionally with NeuRemedy, "The Neuropathy Vitamin."
Thiamine deficiency is a well-known cause of peripheral neuropathy
Adequate blood levels of the micronutrient thiamine are essential for the proper functioning of the peripheral nervous system. Studies have shown that people who are thiamine deficient suffer from bilateral, symmetrical, peripheral neuropathy of the feet and legs.
Reversing thiamine deficiency is often a highly successful method of managing the symptoms of peripheral neuropathy
Many people, including the elderly, diabetics, and patient on certain medications, are unable to maintain adequate thiamine levels through normal dietary means. These people are prone to develop peripheral neuropathy. For these people NeuRemedy, "The Neuropathy Vitamin", may manage their symptoms of peripheral neuropathy by delivering a highly bioactive form of thiamine to where it is needed, the nerve cells. NeuRemedy works to improve the symptoms of peripheral neuropathy not by sedating the patient but by reversing a nutritional deficiency in their nerves.
Many patient experience dramatic relief from their symptoms in a little as three weeks
The active ingredient in NeuRemedy has been proven in multiple double blind, placebo studies to be safe and effective in reducing or eliminating the symptoms associated with peripheral neuropathy. These studies have documented that patients often feel an improvement in symptoms in as little as three weeks. The active ingredient in NeuRemedy, benfotiamine, has been used successfully to nutritionally manage tens of thousands of people suffering from peripheral neuropathy in Europe and Asia for over fifty years. Benfotiamine, is a lipid soluble thiamine, analogue. Thiamine deficiency is a well-known cause of a bilateral, symmetric, peripheral neuropathy characterized by pain, burning, tingling and/or numbness to the feet and legs. A recent groundbreaking English study has demonstrated that both type I and type II diabetics have a 75% decrease in plasma thiamine levels as compared to non-diabetics. The same study demonstrated that diabetics suffer from a 16 to 25-fold increase in renal thiamine clearance as compared to the general population. Diabetics, it seems, lose excessive amounts of thiamine in their urine. The long-term use of furosemide may also lead to thiamine deficiency. Other subgroups that are known to have higher levels of thiamine deficiency than the general population and are more prone to suffer from peripheral neuropathy include the elderly, alcoholics and post-gastric bypass and post gastrectomy patients.
NeuRemedy is an FDA classified medical food intended to be taken under supervision of a physician
As a medical food, NeuRemedy is formulated specifically for the dietary management of peripheral neuropathy. NeuRemedy has no known significant adverse effects and may be safely taken with medicines, medical foods, and vitamins.

Click below to read full citations:

http://www.tritolonen.fi/files/pdf/Stracke_2008.pdf

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1998885/pdf/125_2007_Article_771.pdf